Alpha-D-galactosidase A en es it fr

Alpha-D-galactosidase A Brand names, Alpha-D-galactosidase A Analogs

Alpha-D-galactosidase A Brand Names Mixture

  • No information avaliable

Alpha-D-galactosidase A Chemical_Formula

C2029H3080N544O587S27

Alpha-D-galactosidase A RX_link

http://www.rxlist.com/cgi/generic3/fabrazyme.htm

Alpha-D-galactosidase A fda sheet

Alpha-D-galactosidase A msds (material safety sheet)

Alpha-D-galactosidase A Synthesis Reference

No information avaliable

Alpha-D-galactosidase A Molecular Weight

45351.6

Alpha-D-galactosidase A Melting Point

No information avaliable

Alpha-D-galactosidase A H2O Solubility

No information avaliable

Alpha-D-galactosidase A State

Liquid

Alpha-D-galactosidase A LogP

-0.307

Alpha-D-galactosidase A Dosage Forms

Powder for solution

Alpha-D-galactosidase A Indication

For treatment of Fabry's disease (alpha-galactosidase A deficiency)

Alpha-D-galactosidase A Pharmacology

Used in the treatment of Fabry disease, an X-linked genetic disorder of glycosphingolipid metabolism. The disease is characterized by a deficiency of the lysosomal enzyme alpha-galactosidase A, which leads to progressive accumulation of glycosphingolipids, predominantly GL-3, in many body tissues. Clinical manifestations of Fabry disease include renal failure, cardiomyopathy, and cerebrovascular accidents. Fabrazyme is intended to provide an exogenous source of alpha-galactosidase A and to limit the accumulation of these glycolipids in the tissues.

Alpha-D-galactosidase A Absorption

No information avaliable

Alpha-D-galactosidase A side effects and Toxicity

No information avaliable

Alpha-D-galactosidase A Patient Information

BIOD00075.html

Alpha-D-galactosidase A Organisms Affected

Humans and other mammals